ADAGE CAPITAL PARTNERS GP, L.L.C.'s Net Worth

$2.26 Billion

Estimate Recalculated Feb 28, 2024 08:04PM EST

Who is ADAGE CAPITAL PARTNERS GP, L.L.C.?

ADAGE CAPITAL PARTNERS GP, L.L.C. has an estimated net worth of $2.26 Billion. This is based on reported shares across multiple companies, which include ORBCOMM Inc., HeartWare International, Inc., Royalty Pharma plc, Celanese Corp, SELECT COMFORT CORP, MULESOFT, INC, GCM Grosvenor Inc., Solaris Oilfield Infrastructure, Inc., HUBBELL INC, Protagonist Therapeutics, Inc, Mandalay Digital Group, Inc., PUMA BIOTECHNOLOGY, INC., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., Advaxis, Inc., Nexvet Biopharma plc, AMCI Acquisition Corp., AMAG PHARMACEUTICALS INC., East Resources Acquisition Co, ABEONA THERAPEUTICS INC., PACIFIC SUNWEAR OF CALIFORNIA INC, Vitae Pharmaceuticals, Inc, SMART BALANCE, INC., FIVE PRIME THERAPEUTICS INC, CARDIOME PHARMA CORP, Targanta Therapeutics Corp., GENEVA ACQUISITION CORP, MANTECH INTERNATIONAL CORP, Viggle Inc., iGo, Inc., MED-DESIGN CORP, Alsius Corp, and CPAC INC.

SEC CIK

ADAGE CAPITAL PARTNERS GP, L.L.C.'s CIK is 0001165408

Past Insider Trading and Trends

2006 was ADAGE CAPITAL PARTNERS GP, L.L.C.'s most active year for acquiring shares with 54 total transactions. ADAGE CAPITAL PARTNERS GP, L.L.C.'s most active month to acquire stocks was the month of October. 2017 was ADAGE CAPITAL PARTNERS GP, L.L.C.'s most active year for disposing of shares, totalling 38 transactions. ADAGE CAPITAL PARTNERS GP, L.L.C.'s most active month to dispose stocks was the month of March. 2020 saw ADAGE CAPITAL PARTNERS GP, L.L.C. paying a total of $84,000,000.00 for 46,015,330 shares, this is the most they've acquired in one year. In 2020 ADAGE CAPITAL PARTNERS GP, L.L.C. cashed out on 13,056,561 shares for a total of $333,391,124.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ORBCOMM Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.28%
-100.00K
$4.31
-$431,000.00
7.7M
Aug 12
Form 3
0
0
Form 4
-0.85%
-134.00K
$4.02
-$540,273.69
15.68M
Nov 20 - Nov 21
Form 3
0
0
No matching records found

HeartWare International, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.06%
-110.00K
$91.22
-$10,065,072.00
3.48M
Jul 31 - Aug 3
Form 4
-1.50%
-173.27K
$80.68
-$13,982,322.70
11.34M
Apr 17 - Apr 21
Form 4
+2.62%
100K
$76.94
$7,693,992.80
3.91M
Sep 12 - Sep 15
Form 3
0
0
No matching records found

Royalty Pharma plc (RPRX) Snapshot price: $30

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.87%
-7.30M
$43.92
-$320,672,221.00
38.71M
Dec 17 - Dec 18
Form 4
46.02M
$28.00
$84,000,000.00
46.02M
Jun 18
Form 3
0
0
No matching records found

Celanese Corp (CE) Snapshot price: $149.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

SELECT COMFORT CORP (SNBR) Snapshot price: $9.495

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.78%
-213.00K
$10.20
-$2,172,600.00
5.42M
Feb 9
Form 4
-5.37%
-319.20K
$10.20
-$3,255,490.00
5.63M
Feb 4 - Feb 8
Form 4
-12.73%
-867.80K
$10.08
-$8,748,310.00
5.95M
Feb 1 - Feb 3
Form 4
-2.85%
-200.00K
$10.42
-$2,083,423.03
6.82M
Jan 27 - Jan 31
Form 4
+2.18%
150K
$7.22
$1,082,754.08
7.01M
Mar 19
Form 4
+1.48%
100K
$4.75
$475,000.00
6.87M
Dec 8
Form 4
+1.52%
200K
$1.88
$380,775.54
13.4M
Jul 28 - Jul 29
Form 3
0
0
No matching records found